Conatus Pharmaceuticals (CNAT) PT Lowered to $10 at Oppenheimer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. INTC
2. AMZN
3. RDDT
4. COIN
5. PINS
6. FSLR
7. SYK
8. DASH
9. GILD
10. SBUX

Go back to Conatus Pharmaceuticals (CNAT) PT Lowered to $10 at Oppenheimer

Conatus Pharmaceuticals (CNAT) PT Lowered to $14 at H.C. Wainwright

December 6, 2018 9:16 AM EST

H.C. Wainwright analyst Ed Arce lowered the price target on Conatus Pharmaceuticals (NASDAQ: CNAT) to $14.00 (from $15.00) while maintaining a Buy rating.

Arce commented, "We fully expect CNAT shares to drop over 10% today as some investors will undoubtedly look no further at yesterday's release of the ENCORE-PH top-line results, than to see that the study missed its primary endpoint. Following this expected initial... More